NuVim, Inc.
NUVM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | $0 | $0 |
| - Cash | – | – | $0 | $0 |
| + Debt | – | – | $0 | $0 |
| Enterprise Value | – | – | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | – | 0% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,798% | -2,625% | – | -368.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,874.5% | -2,699.5% | – | -383.8% |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | -$0 | – |
| Capital Expenditures | – | – | $0 | – |
| Free Cash Flow | – | – | -$0 | – |